A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Principal Investigators:

The principal investigators (PIs) will be transplant physicians at all participating U.S. transplant centers.

Study Design:

This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.

Primary Objective:

The primary objective of this study is to examine the incidence of neutrophil recovery of ≥500/mm3 after cord blood transplantation in a multi-institution setting using CBUs that are not Food and Drug Administration (FDA) licensed.

Secondary Objectives:

In patients receiving a non-licensed CBU:

Assess incidence of transmission of infection
Assess incidence of serious infusion reaction
Determine 1 year overall survival after cord blood transplantation
Assess cumulative incidence of acute graft vs. host disease (GVHD) grades II to IV and grades III to IV
Assess cumulative incidence of chronic GVHD
Determine platelet engraftment of >20,000 mcL and >50,000 mcL